$ARDX
ARDELYX, INC. Stock $ardx

$ardx Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000162828024034121 Filed on August 01, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$98.24M	$73.22M
YoY Change	74.21%	227.86%
Cost Of Revenue	$15.73M	$9.436M
YoY Change	104.47%	170.45%
Gross Profit	$82.51M	$63.79M
YoY Change	69.43%	238.5%
Gross Profit Margin	83.99%	87.11%
Selling, General & Admin	$64.97M	$64.65M
YoY Change	98.9%	137.82%
% of Gross Profit	78.74%	101.36%
Research & Development	$15.31M	$12.76M
YoY Change	77.26%	54.09%
% of Gross Profit	18.55%	20.01%
Depreciation & Amortization	$544.0K	$569.0K
YoY Change	87.59%	-10.95%
% of Gross Profit	0.66%	0.89%
Operating Expenses	$80.28M	$77.42M
YoY Change	94.38%	118.27%
Operating Profit	$2.233M	-$13.63M
YoY Change	-69.82%	-18.01%
Interest Expense	-$3.357M	-$3.326M
YoY Change	-403.25%	209.4%
% of Operating Profit	-150.34%
Other Income/Expense, Net	$2.282M	$2.145M
YoY Change	56.3%	271.11%
Pretax Income	-$766.0K	-$16.39M
YoY Change	-111.22%	-4.29%
Income Tax	$43.00K	$67.00K
% Of Pretax Income
Net Earnings	-$809.0K	-$16.45M
YoY Change	-112.2%	-3.9%
Net Earnings / Revenue	-0.82%	-22.47%
Basic Earnings Per Share	$0.00	-$0.07
Diluted Earnings Per Share	$0.00	-$0.07
COMMON SHARES
Basic Shares Outstanding	235.4M shares	234.0M shares
Diluted Shares Outstanding	235.9M shares	234.6M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$190.4M	$186.0M
YoY Change	15.34%	45.76%
Cash & Equivalents	$47.43M	$41.89M
Short-Term Investments	$143.0M	$144.1M
Other Short-Term Assets	$29.12M	$26.06M
YoY Change	19.85%	46.31%
Inventory	$85.16M	$83.43M
Prepaid Expenses
Receivables	$53.20M	$37.24M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$284.1M	$263.0M
YoY Change	17.78%	62.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.028M	$1.016M
YoY Change	-7.89%	-87.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.332M	$5.452M
YoY Change	244.0%	-86.69%
Total Long-Term Assets	$83.77M	$80.47M
YoY Change	73.92%	63.94%
TOTAL ASSETS
Total Short-Term Assets	$284.1M	$263.0M
Total Long-Term Assets	$83.77M	$80.47M
Total Assets	$367.9M	$343.5M
YoY Change	27.12%	62.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.82M	$10.88M
YoY Change	104.55%	105.53%
Accrued Expenses	$47.40M	$40.73M
YoY Change	49.54%	74.16%
Deferred Revenue	$7.272M	$10.83M
YoY Change	78.59%	81.73%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$70.50M	$62.44M
YoY Change	61.96%	1.21%
LONG-TERM LIABILITIES
Long-Term Debt	$100.7M	$100.2M
YoY Change	270.25%
Other Long-Term Liabilities	$38.36M	$33.81M
YoY Change	22464.71%	28.31%
Total Long-Term Liabilities	$139.1M	$134.1M
YoY Change	81704.12%	408.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$70.50M	$62.44M
Total Long-Term Liabilities	$139.1M	$134.1M
Total Liabilities	$209.6M	$196.5M
YoY Change	113.37%	123.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$890.0M	-$889.2M
YoY Change	8.88%	7.91%
Common Stock	$1.048B	$1.036B
YoY Change	3.9%	9.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$158.3M	$147.0M
YoY Change
Total Liabilities & Shareholders Equity	$367.9M	$343.5M
YoY Change	27.12%	62.63%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$809.0K	-$16.45M
YoY Change	-112.2%	-3.9%
Depreciation, Depletion And Amortization	$544.0K	$569.0K
YoY Change	87.59%	-10.95%
Cash From Operating Activities	$501.0K	-$18.43M
YoY Change	-102.33%	25.07%
INVESTING ACTIVITIES
Capital Expenditures	$137.0K	$131.0K
YoY Change	-27.89%	40.86%
Acquisitions
YoY Change
Other Investing Activities	$2.478M	$23.66M
YoY Change	-107.62%	-140.03%
Cash From Investing Activities	$2.341M	$23.53M
YoY Change	-107.16%	-139.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.697M	1.608M
YoY Change	-95.34%	-86.04%
NET CHANGE
Cash From Operating Activities	501.0K	-18.43M
Cash From Investing Activities	2.341M	23.53M
Cash From Financing Activities	2.697M	1.608M
Net Change In Cash	5.539M	6.710M
YoY Change	49.3%	-110.75%
FREE CASH FLOW
Cash From Operating Activities	$501.0K	-$18.43M
Capital Expenditures	$137.0K	$131.0K
Free Cash Flow	$364.0K	-$18.56M
YoY Change	-101.68%	25.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	233818576	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	166816000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1038000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	257000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3791000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	234571192	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	214951127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211009029	shares
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	257000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1608000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10769000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-81000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-16454000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	146990000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18385000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-325000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-42972000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	146990000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	125421000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	337000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	149000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11366000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3199000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-190000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-17121000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	123161000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	98329000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	138000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	337000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	211000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	62085000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6111000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-156000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43894000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	123161000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-42972000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43894000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1004000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	639000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1953000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1821000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18385000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6111000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3411000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2090000	usd
	ardx	Non Cash Royalty Related To Sale Of Future Royalties NonCashRoyaltyRelatedToSaleOfFutureRoyalties	-967000	usd
	ardx	Non Cash Royalty Related To Sale Of Future Royalties NonCashRoyaltyRelatedToSaleOfFutureRoyalties	0	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-2483000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-521000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15210000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1376000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33945000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19566000	usd
	ardx	Increase Decrease In Prepaid Commercial Manufacturing Expense IncreaseDecreaseInPrepaidCommercialManufacturingExpense	-8363000	usd
	ardx	Increase Decrease In Prepaid Commercial Manufacturing Expense IncreaseDecreaseInPrepaidCommercialManufacturingExpense	-401000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4626000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-817000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-257000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5565000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2139000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-668000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2200000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1892000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	11947000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	110000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4616000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1961000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55120000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-59532000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	78112000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	19250000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	56870000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	88127000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	281000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	107000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	20961000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-68984000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	49750000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62085000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	4829000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	349000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	54579000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62434000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20420000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-66082000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21470000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	96140000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4034000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1757000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	272000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	19000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	689000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Stock Issued1 StockIssued1	257000	usd
	us-gaap	Stock Issued1 StockIssued1	337000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes thereto. On an ongoing basis, management evaluates its estimates, including those related to recognition of revenue, clinical trial accruals, contract manufacturing accruals, expected demand for inventory, fair value of assets and liabilities, income taxes and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could materially differ from those estimates.</span></div>
CY2024Q2	us-gaap	Investments And Cash InvestmentsAndCash	186000000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-889200000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41890000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41890000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	144172000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	105000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	144071000	usd
CY2024Q2	ardx	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	186062000	usd
CY2024Q2	ardx	Cash Cash Equivalents And Investments Gross Unrealized Gains CashCashEquivalentsAndInvestmentsGrossUnrealizedGains	4000	usd
CY2024Q2	ardx	Cash Cash Equivalents And Investments Gross Unrealized Losses CashCashEquivalentsAndInvestmentsGrossUnrealizedLosses	105000	usd
CY2024Q2	us-gaap	Investments And Cash InvestmentsAndCash	185961000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21470000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21470000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	162605000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	280000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	56000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	162829000	usd
CY2023Q4	ardx	Investments And Cash Amortized Cost InvestmentsAndCashAmortizedCost	184075000	usd
CY2023Q4	ardx	Cash Cash Equivalents And Investments Gross Unrealized Gains CashCashEquivalentsAndInvestmentsGrossUnrealizedGains	280000	usd
CY2023Q4	ardx	Cash Cash Equivalents And Investments Gross Unrealized Losses CashCashEquivalentsAndInvestmentsGrossUnrealizedLosses	56000	usd
CY2023Q4	us-gaap	Investments And Cash InvestmentsAndCash	184299000	usd
CY2023	ardx	Available For Sale Securities Debt Securities Current Contractual Maturities Maximum AvailableForSaleSecuritiesDebtSecuritiesCurrentContractualMaturitiesMaximum	P1Y
	ardx	Available For Sale Securities Debt Securities Current Contractual Maturities Maximum AvailableForSaleSecuritiesDebtSecuritiesCurrentContractualMaturitiesMaximum	P1Y
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	investment
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	investment
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	25915000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	22920000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	55136000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	24582000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2381000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1985000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	83432000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	49487000	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	13756000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	12448000	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	69676000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	37039000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	83432000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	49487000	usd
CY2024Q2	ardx	Prepaid Commercial Manufacturing PrepaidCommercialManufacturing	14800000	usd
CY2023Q4	ardx	Prepaid Commercial Manufacturing PrepaidCommercialManufacturing	23200000	usd
CY2024Q2	ardx	Prepaid Commercial Manufacturing Non Current PrepaidCommercialManufacturingNonCurrent	0	usd
CY2023Q4	ardx	Prepaid Commercial Manufacturing Non Current PrepaidCommercialManufacturingNonCurrent	4200000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	73222000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22333000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	119245000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33702000	usd
CY2023Q4	ardx	Contract With Customer Gross To Net Sales Accruals ContractWithCustomerGrossToNetSalesAccruals	8628000	usd
	ardx	Contract With Customer Gross To Net Sales Provisions ContractWithCustomerGrossToNetSalesProvisions	44124000	usd
	ardx	Contract With Customer Gross To Credits Or Deductions Issued ContractWithCustomerGrossToCreditsOrDeductionsIssued	-35072000	usd
CY2024Q2	ardx	Contract With Customer Gross To Net Sales Accruals ContractWithCustomerGrossToNetSalesAccruals	17680000	usd
CY2024Q2	ardx	Non Cash Interest Expense Related To Sale Of Royalties NonCashInterestExpenseRelatedToSaleOfRoyalties	1600000	usd
	ardx	Non Cash Interest Expense Related To Sale Of Royalties NonCashInterestExpenseRelatedToSaleOfRoyalties	3300000	usd
CY2023Q2	ardx	Non Cash Interest Expense Related To Sale Of Royalties NonCashInterestExpenseRelatedToSaleOfRoyalties	1000000.0	usd
	ardx	Non Cash Interest Expense Related To Sale Of Royalties NonCashInterestExpenseRelatedToSaleOfRoyalties	1900000	usd
	ardx	Proceeds From Royalty Payments ProceedsFromRoyaltyPayments	400000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	104950000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1047000	usd
CY2024Q2	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	3654000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	100249000	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2024Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	100249000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4324000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5589000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3550000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4435000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1096000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1725000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4646000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6160000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.067
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.068
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1091000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1064000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2137000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2128000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1221000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1100000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2386000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2198000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2487000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1663000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	604000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	117000	usd
CY2024Q2	ardx	Lessee Operating Lease Liability To Be Paid After Year Three LesseeOperatingLeaseLiabilityToBePaidAfterYearThree	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4871000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	225000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4646000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3550000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1096000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10769000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3199000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18385000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6111000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22168000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.20
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7470000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.39
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1564000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	307000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.87
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27767000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.42
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	13276000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.43
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-16454000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-17121000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-42972000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43894000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	234571000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	234571000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	214951000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	214951000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	233819000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	233819000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	211009000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211009000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35957000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	23945000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	34944000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	23471000	shares
CY2024Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	usd
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-034121-index-headers.html	Edgar Link	pending
0001628280-24-034121-index.html	Edgar Link	pending
0001628280-24-034121.txt	Edgar Link	pending
0001628280-24-034121-xbrl.zip	Edgar Link	pending
ardx-20240630.htm	Edgar Link	pending
ardx-20240630.xsd	Edgar Link	pending
ardx-20240630xex311.htm	Edgar Link	pending
ardx-20240630xex312.htm	Edgar Link	pending
ardx-20240630xex321.htm	Edgar Link	pending
ardx-20240630_g1.jpg	Edgar Link	pending
ardx-20240630_cal.xml	Edgar Link	unprocessable
ardx-20240630_def.xml	Edgar Link	unprocessable
exhibit101-xardelyxxamende.htm	Edgar Link	pending
exhibit102-xardelyxxamende.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
ardx-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ardx-20240630_htm.xml	Edgar Link	completed
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ardx-20240630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARDX
ARDELYX, INC. Stock $ardx

2024 Q3 Form 10-Q Financial Statement

#000162828024034121 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARDX ARDELYX, INC. Stock $ardx

2024 Q3 Form 10-Q Financial Statement

#000162828024034121 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARDX
ARDELYX, INC. Stock $ardx